Cargando…

Randomised controlled trial to investigate optimal antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: a study protocol of the OPTIMA-AF trial

INTRODUCTION: The optimal antithrombotic strategy for patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) is uncertain. For patients with non-AF, many trials are now evaluating short 1-month dual antiplatelet therapy. In patients with AF undergoing PCI, in cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sotomi, Yohei, Kozuma, Ken, Kashiwabara, Kosuke, Higuchi, Yoshiharu, Ando, Kenji, Morino, Yoshihiro, Ako, Junya, Tanabe, Kengo, Muramatsu, Takashi, Nakazawa, Gaku, Hikoso, Shungo, Sakata, Yasushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671924/ https://www.ncbi.nlm.nih.gov/pubmed/34907043 http://dx.doi.org/10.1136/bmjopen-2020-048354

Ejemplares similares

What Are Your Expectations for Risk Prediction Tools?
por: Sotomi, Yohei, et al.
Publicado: (2022)

Impact of Direct Oral Anticoagulant Off-Label Reduced Dose in Combination With Antiplatelet Agents on Clinical Outcome　― Propensity Score-Matching Analysis From the DIRECT Real-World Non-Valvular Atrial Fibrillation Registry ―
por: Kobayashi, Tomoaki, et al.
Publicado: (2020)

P2Y12 inhibitor monotherapy after complex percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials
por: Sotomi, Yohei, et al.
Publicado: (2023)

Clinical expert consensus document on drug-coated balloon for coronary artery disease from the Japanese Association of Cardiovascular Intervention and Therapeutics
por: Muramatsu, Takashi, et al.
Publicado: (2023)

Clinical expert consensus document on quantitative coronary angiography from the Japanese Association of Cardiovascular Intervention and Therapeutics
por: Suzuki, Nobuaki, et al.
Publicado: (2020)

Rationale and design of the optimal antithrombotic treatment for acute coronary syndrome patients with concomitant atrial fibrillation and implanted with new‐generation drug‐eluting stent: OPtimal management of anTIthroMbotic Agents (OPTIMA)‐4 trial
por: Gong, Xiaoxuan, et al.
Publicado: (2023)

Prevalence of Valvular and Non-valvular Atrial Fibrillation and the Application of Antithrombotic Treatment in a Tertiary Care Hospital
por: Dhungana, Sahadeb Prasad, et al.
Publicado: (2020)

Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF
por: Kozieł, Monika, et al.
Publicado: (2021)

Serial optical coherence tomography and angioscopic assessments of 10-year in-stent restenosis of Cypher sirolimus-eluting stent treated with drug-coated balloon angioplasty
por: Suzuki, Satoshi, et al.
Publicado: (2019)

Decisiones optimas financieras
por: Robicheck, Alexander
Publicado: (1972)

Decisiones óptimas financieras /
por: Robichek, Alexander A.
Publicado: (1968)

Kwaliteiten optimaal benutten
por: STALPERS, DEWI
Publicado: (2021)

Fuerza óptima : ¿mito o realidad? /
por: Román Suárez, Iván
Publicado: (2006)

Anticoagulation for the prevention of stroke in non-valvular AF in general practice: room for improvement
por: Ioannou, Adam, et al.
Publicado: (2016)

Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study
por: Xiang, Wei, et al.
Publicado: (2015)

The Rate of Clinical Outcomes in Atrial Fibrillation according to Antithrombotic Strategy: The COOL-AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2022)

Antithrombotic Management in AF Patients Following Percutaneous Coronary Intervention: A European Perspective
por: Greco, Antonio, et al.
Publicado: (2023)

Left atrial pressure overload and prognosis in elderly patients with heart failure and preserved ejection fraction: a prospective multicenter observational study
por: Hoshida, Shiro, et al.
Publicado: (2021)

Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial
por: Gessler, Nele, et al.
Publicado: (2021)

Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results
por: Kubo, Takashi, et al.
Publicado: (2017)

The Impact of Prior Antithrombotic Use on Blood Viscosity in Cardioembolic Stroke with Non-Valvular Atrial Fibrillation
por: Jung, Yo-Han, et al.
Publicado: (2023)

Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program
por: Beier, Lea, et al.
Publicado: (2022)

Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke
por: Natsuaki, Masahiro, et al.
Publicado: (2019)

Practical Assessment of the Tradeoff between Fatal Bleeding and Coronary Thrombotic Risks using the Academic Research Consortium for High Bleeding Risk Criteria
por: Sotomi, Yohei, et al.
Publicado: (2022)

Long‐Term Impact of Additional Ablation After Pulmonary Vein Isolation: Results From EARNEST‐PVI Trial
por: Masuda, Masaharu, et al.
Publicado: (2023)

Prognostic significance of serum chloride level in heart failure patients with preserved ejection fraction
por: Seo, Masahiro, et al.
Publicado: (2022)

Clinical Determinants of Quality of Life in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT-Heart Failure With Preserved Ejection Fraction Registry
por: Seo, Masahiro, et al.
Publicado: (2022)

The clinical relevance of quality of life in heart failure patients with preserved ejection fraction
por: Seo, Masahiro, et al.
Publicado: (2022)

Prognostic Significance of Serum Cholinesterase Level in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT‐HFpEF Registry
por: Seo, Masahiro, et al.
Publicado: (2019)

Elevated Plasma Bioactive Adrenomedullin and Mortality in Cardiogenic Shock: Results from the OptimaCC Trial
por: Takagi, Koji, et al.
Publicado: (2021)

Optima and equilibria: an introduction to nonlinear analysis
por: Aubin, Jean-Pierre
Publicado: (1998)

Wear and Friction of UHMWPE-on-PEEK OPTIMA™
por: Cowie, Raelene M., et al.
Publicado: (2019)

Cardiac resynchronisation therapy in optima forma
por: Timmer, S. A. J., et al.
Publicado: (2022)

Cardiac resynchronisation therapy in optima forma
por: Timmer, S. A. J., et al.
Publicado: (2022)

Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry
por: Mazurek, Michał, et al.
Publicado: (2017)

La desilusión óptima del amor : cuentos /
por: Rascón Castro, Cristina, 1976-
Publicado: (2023)

Pre-infarction Angina: Time Interval to Onset of Myocardial Infarction and Comorbidity Predictors
por: Sotomi, Yohei, et al.
Publicado: (2022)

Impact of Angiographic Residual Stenosis on Clinical Outcomes After New‐Generation Drug‐Eluting Stents Implantation: Insights From a Pooled Analysis of the RESET and NEXT Trials
por: Watanabe, Hiroki, et al.
Publicado: (2018)

Quantitative Validation of the Coronary Angioscopic Yellow Plaque with Lipid Core Burden Index Assessed by Intracoronary Near-Infrared Spectroscopy
por: Omatsu, Takashi, et al.
Publicado: (2022)

Relationships of Atrial Fibrillation at Diagnosis and Type of Atrial Fibrillation During Follow-up With Long-Term Outcomes for Heart Failure With Preserved Ejection Fraction
por: Nakatani, Daisaku, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_scoaf3hng6k8uas0g49s3ajbcm